Unknown

Dataset Information

Interleukin-17, a salivary biomarker for COVID-19 severity.


ABSTRACT:

Objectives

T-helper 17 cell-mediated response and their effector IL-17 cytokine induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is a major cause of COVID-19 disease severity and death. Therefore, the study aimed to determine if IL-17 level in saliva mirrors its circulatory level and hence can be used as a non-invasive biomarker for disease severity.

Methods

Interleukin-17 (IL-17) level was evaluated by ELISA in saliva and blood of 201 adult COVID-19 patients with different levels of severity. The IL-17 saliva level was also associated with COVID-19 disease severity, and need for mechanical ventilation and/or death within 29 days after admission of severe COVID-19 patients.

Results

We found that IL-17 level in saliva of COVID-19 patien

SUBMITTER: Sharif-Askari FS 

PROVIDER: S-EPMC9498944 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature